<DOC>
	<DOCNO>NCT00682253</DOCNO>
	<brief_summary>A new imaging modality combine CT tomographic bone scintigraphy ( SPECT/CT ) enable combination functional anatomical imaging . Its use cancer patient yet evaluate validated relative gold stand clinical follow . The purpose study : 1 : validate use conventional planar bone scintigraphy SPECT combine low-dose diagnostic CT compare 3 Tesla MRI clinical follow . 2 : compare specificity low-dose diagnostic CT , respectively , combine bone SPECT . 3 : construct algorithm optimal evaluation disease dissemination breast cancer patient</brief_summary>
	<brief_title>Use Bone Scintigraphy , CT MRI Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histological verify breast cancer Age 1880 year Investigation metastases use image modality/modalities plan Written consent participate trial Overweight limiting use MRI Metal part body Claustrophobia Allergy contrast agent use trial Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>SPECT/CT</keyword>
	<keyword>MRI</keyword>
	<keyword>Breast neoplasm</keyword>
</DOC>